<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04825158</url>
  </required_header>
  <id_info>
    <org_study_id>8030</org_study_id>
    <nct_id>NCT04825158</nct_id>
  </id_info>
  <brief_title>Study of the Role of Hemostasis in Perioperative Anaphylaxis</brief_title>
  <acronym>HEMOCANOPE</acronym>
  <official_title>Study of the Role of Hemostasis in Perioperative Anaphylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anaphylaxis is a severe and life-threatening complication during the perioperative period.&#xD;
      Perioperative anaphylaxis is still associated with a significant mortality despite quick and&#xD;
      efficient management using epinephrine, the mainstay of acute treatment. Experimental data&#xD;
      and few case reports are suggesting that hemostasis, and more precisely platelets, could play&#xD;
      a role in anaphylaxis. Our main hypothesis is that activation of the hemostatic system&#xD;
      contributes to the severity of the reaction&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">February 9, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Platelet activation</measure>
    <time_frame>As soon as possible after onset of anaphylaxis</time_frame>
    <description>Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet activation</measure>
    <time_frame>1-2 hours after the onset of anaphylaxis</time_frame>
    <description>Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet activation</measure>
    <time_frame>24 hours after the onset of anaphylaxis</time_frame>
    <description>Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet activation</measure>
    <time_frame>During the allergic workup (4-6 weeks after)</time_frame>
    <description>Measurement of: Plasmatic serotonin level, Plasmatic PF-4 level, P-selectin expression (MFI, %), Platelet count</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hemoptysis</condition>
  <condition>Perioperative Complication</condition>
  <condition>Anaphylaxis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  Whole blood&#xD;
&#xD;
        -  Plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study will focus on any adult patient with a suspected diagnosis of perioperative&#xD;
        anaphylactic shock&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient, male or female, adult&#xD;
&#xD;
          -  In the perioperative period&#xD;
&#xD;
          -  In whom the diagnosis of anaphylactic shock is suggested&#xD;
&#xD;
          -  Patient is giving his consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject under legal protection&#xD;
&#xD;
          -  Subject under guardianship or guardianship&#xD;
&#xD;
          -  Anemia less than 7 g /dl at the time of inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Charles-Ambroise TACQUARD, PHD</last_name>
    <phone>+333 69 55 16 08</phone>
    <email>charlesambroise.tacquard@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xavier DELABRANCHE, PHD</last_name>
    <phone>03.69.55.09.36</phone>
    <email>Xavier.delabranche@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 21, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 30, 2021</last_update_submitted>
  <last_update_submitted_qc>March 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemoptysis</mesh_term>
    <mesh_term>Anaphylaxis</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

